Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Hematopoietic Stem Cell Mobilization"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 1203
Tytuł:
Platelet-derived circulating soluble P-selectin is sufficient to induce hematopoietic stem cell mobilization.
Autorzy:
Wang TF; Department of Hematology and Oncology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan, Republic of China.; Department of Medicine, College of Medicine, Tzu Chi University, Hualien, Taiwan, Republic of China.; Buddhist Tzu Chi Stem Cells Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan, Republic of China.
Liou YS; Department of Molecular Biology and Human Genetics, College of Medicine, Tzu Chi University, No. 701, Section 3, Zhong-Yang Road, Hualien, 97004, Taiwan, Republic of China.
Yang SH; Department of Medicine, College of Medicine, Tzu Chi University, Hualien, Taiwan, Republic of China.; Buddhist Tzu Chi Stem Cells Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan, Republic of China.; Department of Pediatric Hematology and Oncology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan, Republic of China.
Lin GL; Department of Molecular Biology and Human Genetics, College of Medicine, Tzu Chi University, No. 701, Section 3, Zhong-Yang Road, Hualien, 97004, Taiwan, Republic of China.; Integration Center of Traditional Chinese and Modern Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan, Republic of China.
Chiang YW; Department of Molecular Biology and Human Genetics, College of Medicine, Tzu Chi University, No. 701, Section 3, Zhong-Yang Road, Hualien, 97004, Taiwan, Republic of China.
Lien TS; Department of Molecular Biology and Human Genetics, College of Medicine, Tzu Chi University, No. 701, Section 3, Zhong-Yang Road, Hualien, 97004, Taiwan, Republic of China.
Li CC; Department of Hematology and Oncology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan, Republic of China.; Center of Stem Cell and Precision Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan, Republic of China.
Wang JH; Department of Medical Research, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan, Republic of China.
Chang HH; Department of Molecular Biology and Human Genetics, College of Medicine, Tzu Chi University, No. 701, Section 3, Zhong-Yang Road, Hualien, 97004, Taiwan, Republic of China. .
Sun DS; Department of Molecular Biology and Human Genetics, College of Medicine, Tzu Chi University, No. 701, Section 3, Zhong-Yang Road, Hualien, 97004, Taiwan, Republic of China. .
Pokaż więcej
Źródło:
Stem cell research & therapy [Stem Cell Res Ther] 2023 Oct 20; Vol. 14 (1), pp. 300. Date of Electronic Publication: 2023 Oct 20.
Typ publikacji:
Journal Article
MeSH Terms:
Hematopoietic Stem Cell Mobilization*/methods
P-Selectin*/genetics
P-Selectin*/metabolism
Male ; Mice ; Humans ; Animals ; Mice, Inbred C57BL ; Hematopoietic Stem Cells/metabolism ; Granulocyte Colony-Stimulating Factor/pharmacology ; Granulocyte Colony-Stimulating Factor/metabolism ; Recombinant Proteins/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Stem Cells Collection and Mobilization in Adult Autologous/Allogeneic Transplantation: Critical Points and Future Challenges.
Autorzy:
Prisciandaro M; Operative Research Unit of Transfusion Medicine and Cellular Therapy, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Roma, Italy.
Santinelli E; Operative Research Unit of Hematology and Stem Cell Transplantation, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Roma, Italy.; Program in Immunology, Molecular Medicine and Applied Biotechnologies, Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy.
Tomarchio V; Operative Research Unit of Hematology and Stem Cell Transplantation, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Roma, Italy.
Tafuri MA; Operative Research Unit of Hematology and Stem Cell Transplantation, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Roma, Italy.
Bonchi C; Operative Research Unit of Transfusion Medicine and Cellular Therapy, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Roma, Italy.
Palazzo G; Operative Research Unit of Transfusion Medicine and Cellular Therapy, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Roma, Italy.
Nobile C; Operative Research Unit of Transfusion Medicine and Cellular Therapy, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Roma, Italy.
Marinucci A; Operative Research Unit of Transfusion Medicine and Cellular Therapy, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Roma, Italy.
Mele M; Operative Research Unit of Hematology and Stem Cell Transplantation, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Roma, Italy.
Annibali O; Operative Research Unit of Hematology and Stem Cell Transplantation, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Roma, Italy.
Rigacci L; Operative Research Unit of Hematology and Stem Cell Transplantation, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Roma, Italy.
Vacca M; Operative Research Unit of Transfusion Medicine and Cellular Therapy, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Roma, Italy.
Pokaż więcej
Źródło:
Cells [Cells] 2024 Mar 28; Vol. 13 (7). Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Hematopoietic Stem Cell Transplantation*
Blood Component Removal*/methods
Adult ; Humans ; Hematopoietic Stem Cell Mobilization/methods ; Transplantation, Homologous ; Hematopoietic Stem Cells
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Research progress of the chemokine/chemokine receptor axes in the oncobiology of multiple myeloma (MM).
Autorzy:
Du J; Department of Hematology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
Lin Z; Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Fu XH; Department of Hematology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
Gu XR; Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Lu G; Department of Hematology, Shengli Oilfield Central Hospital, Dongying, 257099, China. .
Hou J; Department of Hematology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China. .
Pokaż więcej
Źródło:
Cell communication and signaling : CCS [Cell Commun Signal] 2024 Mar 12; Vol. 22 (1), pp. 177. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Multiple Myeloma*
Heterocyclic Compounds*
Humans ; Hematopoietic Stem Cell Mobilization ; Chemokines ; Signal Transduction ; Biomarkers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients: a single centre experience from the GMMG-HD6 and -HD7 trials.
Autorzy:
Kauer J; Department of Haematology, Oncology and Rheumatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.
Freundt EP; Department of Haematology, Oncology and Rheumatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
Schmitt A; Department of Haematology, Oncology and Rheumatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
Weinhold N; Department of Haematology, Oncology and Rheumatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
Mai EK; Department of Haematology, Oncology and Rheumatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; GMMG Study Group at University Hospital Heidelberg, Heidelberg, Germany.
Müller-Tidow C; Department of Haematology, Oncology and Rheumatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.; National Centre for Tumour Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
Goldschmidt H; Department of Haematology, Oncology and Rheumatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; GMMG Study Group at University Hospital Heidelberg, Heidelberg, Germany.; National Centre for Tumour Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
Raab MS; Department of Haematology, Oncology and Rheumatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; National Centre for Tumour Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
Kriegsmann K; Department of Haematology, Oncology and Rheumatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Laborarztpraxis, Laborarztpraxis Rhein-Main MVZ GbR, Limbach Gruppe SE, Frankfurt Am Main, Germany.
Sauer S; Department of Haematology, Oncology and Rheumatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Nov 21; Vol. 23 (1), pp. 1132. Date of Electronic Publication: 2023 Nov 21.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
MeSH Terms:
Heterocyclic Compounds*/therapeutic use
Multiple Myeloma*/drug therapy
Multiple Myeloma*/diagnosis
Peripheral Blood Stem Cell Transplantation*
Humans ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bortezomib/therapeutic use ; Dexamethasone/therapeutic use ; Hematopoietic Stem Cell Mobilization/methods ; Lenalidomide/therapeutic use ; Transplantation, Autologous
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy of hematopoietic stem cell mobilization regimens in patients with hematological malignancies: a systematic review and network meta-analysis of randomized controlled trials.
Autorzy:
Luo C; Center for Hematology, Southwest Hospital, Third Military Medical University, #30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China.; Key Laboratory of Cancer Immunotherapy of Chongqing, Chongqing, China.
Wu G; Center for Hematology, Southwest Hospital, Third Military Medical University, #30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China.; Key Laboratory of Cancer Immunotherapy of Chongqing, Chongqing, China.
Huang X; Center for Hematology, Southwest Hospital, Third Military Medical University, #30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China.; Key Laboratory of Cancer Immunotherapy of Chongqing, Chongqing, China.
Zhang Y; Center for Hematology, Southwest Hospital, Third Military Medical University, #30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China.; Key Laboratory of Cancer Immunotherapy of Chongqing, Chongqing, China.
Ma Y; Center for Hematology, Southwest Hospital, Third Military Medical University, #30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China.; Key Laboratory of Cancer Immunotherapy of Chongqing, Chongqing, China.
Huang Y; Center for Hematology, Southwest Hospital, Third Military Medical University, #30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China.; Key Laboratory of Cancer Immunotherapy of Chongqing, Chongqing, China.
Huang Z; Center for Hematology, Southwest Hospital, Third Military Medical University, #30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China.; Key Laboratory of Cancer Immunotherapy of Chongqing, Chongqing, China.
Li H; Center for Hematology, Southwest Hospital, Third Military Medical University, #30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China.; Key Laboratory of Cancer Immunotherapy of Chongqing, Chongqing, China.
Hou Y; Center for Hematology, Southwest Hospital, Third Military Medical University, #30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China.; Key Laboratory of Cancer Immunotherapy of Chongqing, Chongqing, China.
Chen J; Center for Hematology, Southwest Hospital, Third Military Medical University, #30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China.; Key Laboratory of Cancer Immunotherapy of Chongqing, Chongqing, China.
Li X; Institute of Infectious Disease, Southwest Hospital, Third Military Medical University, #30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China. .
Xu S; Center for Hematology, Southwest Hospital, Third Military Medical University, #30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China. .; Key Laboratory of Cancer Immunotherapy of Chongqing, Chongqing, China. .
Pokaż więcej
Źródło:
Stem cell research & therapy [Stem Cell Res Ther] 2022 Mar 22; Vol. 13 (1), pp. 123. Date of Electronic Publication: 2022 Mar 22.
Typ publikacji:
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms:
Hematologic Neoplasms*/therapy
Hematopoietic Stem Cell Mobilization*/methods
Humans ; Network Meta-Analysis ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
GPC-100, a novel CXCR4 antagonist, improves in vivo hematopoietic cell mobilization when combined with propranolol.
Autorzy:
Sukhtankar DD; GPCR Therapeutics USA, Inc., Redwood City, California, United States of America.
Fung JJ; GPCR Therapeutics USA, Inc., Redwood City, California, United States of America.
Kim MN; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea.
Cayton T; GPCR Therapeutics USA, Inc., Redwood City, California, United States of America.
Chiou V; GPCR Therapeutics USA, Inc., Redwood City, California, United States of America.
Caculitan NG; GPCR Therapeutics USA, Inc., Redwood City, California, United States of America.
Zalicki P; GPCR Therapeutics USA, Inc., Redwood City, California, United States of America.
Kim S; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea.
Jo Y; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea.
Kim S; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea.
Lee JM; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea.
Choi J; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea.
Mun S; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea.
Chin A; GPCR Therapeutics USA, Inc., Redwood City, California, United States of America.
Jang Y; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea.
Lee JY; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea.
Kim G; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea.
Kim EH; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea.
Huh WK; School of Biological Sciences, Seoul National University, Seoul, Republic of Korea.; Institute of Microbiology, Seoul National University, Seoul, Republic of Korea.
Jeong JY; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea.
Seen DS; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea.
Cardarelli PM; GPCR Therapeutics USA, Inc., Redwood City, California, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Oct 25; Vol. 18 (10), pp. e0287863. Date of Electronic Publication: 2023 Oct 25 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Multiple Myeloma*/drug therapy
Heterocyclic Compounds*/therapeutic use
Hematopoietic Stem Cell Transplantation*
Animals ; Mice ; Hematopoietic Stem Cell Mobilization/methods ; Propranolol/therapeutic use ; Calcium/metabolism ; Hematopoietic Stem Cells/metabolism ; Receptors, CXCR4/metabolism ; Granulocyte Colony-Stimulating Factor/pharmacology ; beta-Arrestins/metabolism ; Benzylamines/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Inhibition of Cxcr4 Disrupts Mouse Embryonic Palatal Mesenchymal Cell Migration and Induces Cleft Palate Occurrence.
Autorzy:
Zheng X; Laboratory of Orofacial Development, Laboratory of Molecular Signaling and Stem Cells Therapy, Molecular Laboratory for Gene Therapy and Tooth Regeneration, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, Capital Medical University School of Stomatology, Tiantan Xili No. 4, Beijing 100050, China.
Zhao X; Laboratory of Orofacial Development, Laboratory of Molecular Signaling and Stem Cells Therapy, Molecular Laboratory for Gene Therapy and Tooth Regeneration, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, Capital Medical University School of Stomatology, Tiantan Xili No. 4, Beijing 100050, China.
Wang Y; Laboratory of Orofacial Development, Laboratory of Molecular Signaling and Stem Cells Therapy, Molecular Laboratory for Gene Therapy and Tooth Regeneration, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, Capital Medical University School of Stomatology, Tiantan Xili No. 4, Beijing 100050, China.
Chen J; Laboratory of Orofacial Development, Laboratory of Molecular Signaling and Stem Cells Therapy, Molecular Laboratory for Gene Therapy and Tooth Regeneration, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, Capital Medical University School of Stomatology, Tiantan Xili No. 4, Beijing 100050, China.
Wang X; Laboratory of Orofacial Development, Laboratory of Molecular Signaling and Stem Cells Therapy, Molecular Laboratory for Gene Therapy and Tooth Regeneration, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, Capital Medical University School of Stomatology, Tiantan Xili No. 4, Beijing 100050, China.
Peng X; Laboratory of Orofacial Development, Laboratory of Molecular Signaling and Stem Cells Therapy, Molecular Laboratory for Gene Therapy and Tooth Regeneration, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, Capital Medical University School of Stomatology, Tiantan Xili No. 4, Beijing 100050, China.
Ma L; Laboratory of Orofacial Development, Laboratory of Molecular Signaling and Stem Cells Therapy, Molecular Laboratory for Gene Therapy and Tooth Regeneration, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, Capital Medical University School of Stomatology, Tiantan Xili No. 4, Beijing 100050, China.
Du J; Laboratory of Orofacial Development, Laboratory of Molecular Signaling and Stem Cells Therapy, Molecular Laboratory for Gene Therapy and Tooth Regeneration, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, Capital Medical University School of Stomatology, Tiantan Xili No. 4, Beijing 100050, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Aug 13; Vol. 24 (16). Date of Electronic Publication: 2023 Aug 13.
Typ publikacji:
Journal Article
MeSH Terms:
Cleft Palate*/chemically induced
Cleft Palate*/genetics
Heterocyclic Compounds*/pharmacology
Female ; Pregnancy ; Animals ; Mice ; Hematopoietic Stem Cell Mobilization ; Cell Movement
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Superior physical and mental health of healthy volunteers before and five years after mobilized stem cell donation.
Autorzy:
Heyn J; Hexal AG (a Sandoz Company), Holzkirchen, Germany.
Bräuninger S; German Red Cross Blood Service Baden-Württemberg-Hessen, Institute Frankfurt, Frankfurt, Germany.
Dimova-Dobreva M; Hexal AG (a Sandoz Company), Holzkirchen, Germany.
Mathieson N; Hexal AG (a Sandoz Company), Holzkirchen, Germany.
Koptelova N; Hexal AG (a Sandoz Company), Holzkirchen, Germany.
Kolpakova A; Hexal AG (a Sandoz Company), Holzkirchen, Germany.
Seidl C; German Red Cross Blood Service Baden-Württemberg-Hessen, Institute Frankfurt, Frankfurt, Germany.
Reinhardt P; Institut für Klinische Transfusionsmedizin und Immungenetik Ulm (IKT), Ulm, Germany.
Tsamadou C; Institut für Klinische Transfusionsmedizin und Immungenetik Ulm (IKT), Ulm, Germany.
Schrezenmeier H; Institut für Klinische Transfusionsmedizin und Immungenetik Ulm (IKT), Ulm, Germany.
Nakov R; Hexal AG (a Sandoz Company), Holzkirchen, Germany.
Seifried E; German Red Cross Blood Service Baden-Württemberg-Hessen, Institute Frankfurt, Frankfurt, Germany.; Institute for Transfusion Medicine and Immunohematology, Goethe University, Haus 76 Sandhofstr. 1, 60528, Frankfurt a.M., Germany.
Bonig H; German Red Cross Blood Service Baden-Württemberg-Hessen, Institute Frankfurt, Frankfurt, Germany. .; Institute for Transfusion Medicine and Immunohematology, Goethe University, Haus 76 Sandhofstr. 1, 60528, Frankfurt a.M., Germany. .; Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2022 Mar 14; Vol. 20 (1), pp. 121. Date of Electronic Publication: 2022 Mar 14.
Typ publikacji:
Clinical Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hematopoietic Stem Cell Mobilization*
Mental Health*
Granulocyte Colony-Stimulating Factor/pharmacology ; Healthy Volunteers ; Hematopoietic Stem Cells ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A novel PEGylated form of granulocyte colony-stimulating factor, mecapegfilgrastim, for peripheral blood stem cell mobilization in patients with hematologic malignancies.
Autorzy:
Wen J; Department of Hematology, School of Medicine, Mianyang Central Hospital, University of Electronic Science and Technology of China, No 12. Changjia alley, Jingzhong Street, Fucheng district, Mianyang, 621000, China.
Zhou Q; Department of Hematology, School of Medicine, Mianyang Central Hospital, University of Electronic Science and Technology of China, No 12. Changjia alley, Jingzhong Street, Fucheng district, Mianyang, 621000, China.
Shi L; Department of Hematology of Beijing Friendship Hospital, Capital Medical University, Beijing, 100000, China.
Xu F; Department of Hematology, School of Medicine, Mianyang Central Hospital, University of Electronic Science and Technology of China, No 12. Changjia alley, Jingzhong Street, Fucheng district, Mianyang, 621000, China. .
Liu Y; Department of Hematology, School of Medicine, Mianyang Central Hospital, University of Electronic Science and Technology of China, No 12. Changjia alley, Jingzhong Street, Fucheng district, Mianyang, 621000, China.
Su J; Department of Hematology, School of Medicine, Mianyang Central Hospital, University of Electronic Science and Technology of China, No 12. Changjia alley, Jingzhong Street, Fucheng district, Mianyang, 621000, China.
Zhang Y; Department of Hematology, School of Medicine, Mianyang Central Hospital, University of Electronic Science and Technology of China, No 12. Changjia alley, Jingzhong Street, Fucheng district, Mianyang, 621000, China.
Qu W; Department of Hematology, School of Medicine, Mianyang Central Hospital, University of Electronic Science and Technology of China, No 12. Changjia alley, Jingzhong Street, Fucheng district, Mianyang, 621000, China.
Yue J; Department of Hematology, School of Medicine, Mianyang Central Hospital, University of Electronic Science and Technology of China, No 12. Changjia alley, Jingzhong Street, Fucheng district, Mianyang, 621000, China.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Jul 24; Vol. 23 (1), pp. 694. Date of Electronic Publication: 2023 Jul 24.
Typ publikacji:
Journal Article
MeSH Terms:
Peripheral Blood Stem Cells*
Heterocyclic Compounds*
Hematologic Neoplasms*
Humans ; Hematopoietic Stem Cell Mobilization ; Retrospective Studies ; Granulocyte Colony-Stimulating Factor ; Polyethylene Glycols ; Leukocyte Count
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
CMV Seropositive Status Increases Heparanase SNPs Regulatory Activity, Risk of Acute GVHD and Yield of CD34 Cell Mobilization.
Autorzy:
Ostrovsky O; Chaim Sheba Medical Center, Department of Hematology and Bone Marrow Transplantation, Tel-Hashomer, Ramat Gan 5266202, Israel.
Beider K; Chaim Sheba Medical Center, Department of Hematology and Bone Marrow Transplantation, Tel-Hashomer, Ramat Gan 5266202, Israel.
Morgulis Y; Chaim Sheba Medical Center, Department of Hematology and Bone Marrow Transplantation, Tel-Hashomer, Ramat Gan 5266202, Israel.
Bloom N; Chaim Sheba Medical Center, Department of Hematology and Bone Marrow Transplantation, Tel-Hashomer, Ramat Gan 5266202, Israel.
Cid-Arregui A; German Cancer Research Center, D-69120 Heidelberg, Germany.
Shimoni A; Chaim Sheba Medical Center, Department of Hematology and Bone Marrow Transplantation, Tel-Hashomer, Ramat Gan 5266202, Israel.
Vlodavsky I; Technion Integrated Cancer Center, Rappaport Faculty of Medicine, Technion, Haifa 3525433, Israel.
Nagler A; Chaim Sheba Medical Center, Department of Hematology and Bone Marrow Transplantation, Tel-Hashomer, Ramat Gan 5266202, Israel.
Pokaż więcej
Źródło:
Cells [Cells] 2021 Dec 10; Vol. 10 (12). Date of Electronic Publication: 2021 Dec 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hematopoietic Stem Cell Mobilization*
Antigens, CD34/*metabolism
Cytomegalovirus/*physiology
Glucuronidase/*genetics
Graft vs Host Disease/*genetics
Graft vs Host Disease/*virology
Polymorphism, Single Nucleotide/*genetics
Acute Disease ; Cytomegalovirus Infections/genetics ; Cytomegalovirus Infections/virology ; Female ; Gene Frequency/genetics ; Granulocyte Colony-Stimulating Factor/pharmacology ; Humans ; Male ; Risk Factors ; Tissue Donors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
New insight into the mechanism of granulocyte colony-stimulating factor (G-CSF) that induces the mobilization of neutrophils.
Autorzy:
Theyab A; Department of Laboratory Medicine, Security Forces Hospital, Mecca, Saudi Arabia.
Algahtani M; Department of Laboratory Medicine, Security Forces Hospital, Mecca, Saudi Arabia.
Alsharif KF; Department of Clinical Laboratory Science, Collage of Applied Medical Science, Taif University, Saudi Arabia.
Hawsawi YM; Research Center, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia.
Alghamdi A; Department of internal medicine, Security Forces Hospital, Mecca, Saudi Arabia.
Alghamdi A; Batterjee Medical College, Jeddah, Saudi Arabia.
Akinwale J; Discovery - Protein Production at Crescendo Biologics Limited, Cambridge, England, United Kingdom.
Pokaż więcej
Źródło:
Hematology (Amsterdam, Netherlands) [Hematology] 2021 Dec; Vol. 26 (1), pp. 628-636.
Typ publikacji:
Historical Article; Journal Article; Review; Video-Audio Media
MeSH Terms:
Hematopoietic Stem Cell Mobilization*
Hematopoietic Stem Cell Transplantation*
Granulocyte Colony-Stimulating Factor/*metabolism
Granulocyte Colony-Stimulating Factor/*therapeutic use
Hematopoietic Stem Cells/*metabolism
Neutropenia/*metabolism
Neutrophils/*metabolism
Granulocyte Colony-Stimulating Factor/history ; Hematopoietic Stem Cells/pathology ; History, 20th Century ; History, 21st Century ; Humans ; Neutropenia/pathology ; Neutropenia/therapy ; Neutrophils/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Feasibility of six cycles of lenalidomide-based triplet induction before stem cell collection for newly diagnosed transplant-eligible multiple myeloma.
Autorzy:
Yoshihara S; Department of Hematology, Hyogo College of Medicine Hospital, Hyogo, Japan.; Department of Transfusion Medicine and Cellular Therapy, Hyogo College of Medicine Hospital, Hyogo, Japan.
Yoshihara K; Department of Hematology, Hyogo College of Medicine Hospital, Hyogo, Japan.
Shimizu Y; Department of Hematology, Takarazuka City Hospital, Hyogo, Japan.
Imado T; Department of Hematology, Takarazuka City Hospital, Hyogo, Japan.
Takatsuka H; Department of Hematology, Amagasaki Chuo Hospital, Hyogo, Japan.
Kawamoto H; Department of Hematology, Uegahara Hospital, Hyogo, Japan.
Misawa M; Department of Hematology, Ako Central Hospital, Hyogo, Japan.
Ifuku H; Department of Hematology, Amagasaki Chuo Hospital, Hyogo, Japan.
Ohe Y; Department of Hematology, Uegahara Hospital, Hyogo, Japan.
Okada M; Department of Hematology, Hyogo College of Medicine Hospital, Hyogo, Japan.
Fujimori Y; Department of Hematology, Hyogo College of Medicine Hospital, Hyogo, Japan.; Department of Transfusion Medicine and Cellular Therapy, Hyogo College of Medicine Hospital, Hyogo, Japan.; Department of Hematology, Uegahara Hospital, Hyogo, Japan.
Pokaż więcej
Źródło:
Hematology (Amsterdam, Netherlands) [Hematology] 2021 Dec; Vol. 26 (1), pp. 388-392.
Typ publikacji:
Clinical Trial; Journal Article; Multicenter Study; Video-Audio Media
MeSH Terms:
Hematopoietic Stem Cell Mobilization*
Induction Chemotherapy*
Multiple Myeloma*/blood
Multiple Myeloma*/diagnosis
Multiple Myeloma*/therapy
Lenalidomide/*administration & dosage
Adult ; Aged ; Bortezomib/administration & dosage ; Dexamethasone ; Feasibility Studies ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Comparison of the efficacy of hematopoietic stem cell mobilization regimens: a systematic review and network meta-analysis of preclinical studies.
Autorzy:
Luo C; Center for Hematology, Southwest Hospital, Third Military Medical University, #30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China.; Key Laboratory of Cancer Immunotherapy of Chongqing, Chongqing, China.
Wang L; Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Wu G; Center for Hematology, Southwest Hospital, Third Military Medical University, #30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China.; Key Laboratory of Cancer Immunotherapy of Chongqing, Chongqing, China.
Huang X; Center for Hematology, Southwest Hospital, Third Military Medical University, #30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China.; Key Laboratory of Cancer Immunotherapy of Chongqing, Chongqing, China.
Zhang Y; Center for Hematology, Southwest Hospital, Third Military Medical University, #30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China.; Key Laboratory of Cancer Immunotherapy of Chongqing, Chongqing, China.
Ma Y; Center for Hematology, Southwest Hospital, Third Military Medical University, #30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China.; Key Laboratory of Cancer Immunotherapy of Chongqing, Chongqing, China.
Xie M; Center for Hematology, Southwest Hospital, Third Military Medical University, #30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China.; Key Laboratory of Cancer Immunotherapy of Chongqing, Chongqing, China.
Sun Y; Center for Hematology, Southwest Hospital, Third Military Medical University, #30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China.; Key Laboratory of Cancer Immunotherapy of Chongqing, Chongqing, China.
Huang Y; Center for Hematology, Southwest Hospital, Third Military Medical University, #30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China.; Key Laboratory of Cancer Immunotherapy of Chongqing, Chongqing, China.
Huang Z; Center for Hematology, Southwest Hospital, Third Military Medical University, #30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China.; Key Laboratory of Cancer Immunotherapy of Chongqing, Chongqing, China.
Song Q; Department of Health Statistics, Third Military Medical University, Chongqing, China.
Li H; Center for Hematology, Southwest Hospital, Third Military Medical University, #30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China.; Key Laboratory of Cancer Immunotherapy of Chongqing, Chongqing, China.
Hou Y; Center for Hematology, Southwest Hospital, Third Military Medical University, #30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China.; Key Laboratory of Cancer Immunotherapy of Chongqing, Chongqing, China.
Li X; Institute of Infectious Disease, Southwest Hospital, Third Military Medical University, #30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China. .
Xu S; Center for Hematology, Southwest Hospital, Third Military Medical University, #30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China. .; Key Laboratory of Cancer Immunotherapy of Chongqing, Chongqing, China. .
Chen J; Center for Hematology, Southwest Hospital, Third Military Medical University, #30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China. .; Key Laboratory of Cancer Immunotherapy of Chongqing, Chongqing, China. .
Pokaż więcej
Źródło:
Stem cell research & therapy [Stem Cell Res Ther] 2021 May 29; Vol. 12 (1), pp. 310. Date of Electronic Publication: 2021 May 29.
Typ publikacji:
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms:
Hematopoietic Stem Cell Mobilization*
Hematopoietic Stem Cell Transplantation*
Animals ; Bayes Theorem ; Granulocyte Colony-Stimulating Factor/pharmacology ; Mice ; Mice, Inbred C57BL ; Network Meta-Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients: Prospective multicenter observational study (KMM122).
Autorzy:
Jung EH; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
Byun JM; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.; Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea.
Shin DY; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.; Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea.
Do YR; Department of Internal Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, South Korea.
Jo JC; Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.
Lee SM; Department of Internal Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea.
Yoon SS; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.; Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Apr; Vol. 12 (8), pp. 9186-9193. Date of Electronic Publication: 2023 Mar 23.
Typ publikacji:
Observational Study; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Multiple Myeloma*/therapy
Hematopoietic Stem Cell Transplantation*/adverse effects
Humans ; Lenograstim ; Prospective Studies ; Hematopoietic Stem Cell Mobilization ; Filgrastim ; Granulocyte Colony-Stimulating Factor ; Hematopoietic Stem Cells/metabolism ; Recombinant Proteins ; Antigens, CD34/metabolism ; Transplantation, Autologous
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prediction of blood volume to be processed to achieve a target number of CD34+ cells: Development, validation and implementation of a formula.
Autorzy:
García-García I; Department of Haematology and Hemotherapy, Hospital Ramón y Cajal, Madrid, Spain.
Cid J; Apheresis & Cellular Therapy Unit, Department of Hemotherapy and Haemostasis, ICMHO, IDIBAPS, Hospital Clínic, University of Barcelona, Barcelona, Spain.
Moreno-Jiménez G; Department of Haematology and Hemotherapy, Hospital Ramón y Cajal, Madrid, Spain.
Tenorio Núñez M; Department of Haematology and Hemotherapy, Hospital Ramón y Cajal, Madrid, Spain.
Jiménez Martín A; Department of Haematology and Hemotherapy, Hospital Ramón y Cajal, Madrid, Spain.
Vallés Carboneras A; Department of Haematology and Hemotherapy, Hospital Ramón y Cajal, Madrid, Spain.
Velázquez-Kennedy K; Department of Haematology and Hemotherapy, Hospital Ramón y Cajal, Madrid, Spain.
Lozano M; Apheresis & Cellular Therapy Unit, Department of Hemotherapy and Haemostasis, ICMHO, IDIBAPS, Hospital Clínic, University of Barcelona, Barcelona, Spain.
López-Jiménez FJ; Department of Haematology and Hemotherapy, Hospital Ramón y Cajal, Madrid, Spain.
Pokaż więcej
Źródło:
Vox sanguinis [Vox Sang] 2023 Apr; Vol. 118 (4), pp. 288-295. Date of Electronic Publication: 2023 Feb 05.
Typ publikacji:
Journal Article
MeSH Terms:
Blood Component Removal*/methods
Multiple Myeloma*
Humans ; Antigens, CD34 ; Tissue Donors ; Blood Volume ; Hematopoietic Stem Cell Mobilization/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prediction of mobilized hematopoietic stem cell yield in patients with multiple myeloma: Usefulness of whole-body MRI-derived indices.
Autorzy:
Takasu M; Department of Diagnostic Radiology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
Higashino R; Department of Diagnostic Radiology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
Sueoka T; Department of Diagnostic Radiology, Hiroshima Prefectural Hospital, Hiroshima, Japan.
Kawai S; Department of Diagnostic Radiology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
Tanitame N; Department of Diagnostic Radiology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
Tamura A; Department of Diagnostic Radiology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
Iida M; Department of Diagnostic Radiology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
Kawase T; Department of Immune Regenerative Medicine, International Center for Cell and Gene Therapy, Research Promotion and Support Headquarters, Fujita Health University, Aichi, Japan.
Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, Japan.
Awai K; Department of Diagnostic Radiology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Mar 31; Vol. 18 (3), pp. e0283241. Date of Electronic Publication: 2023 Mar 31 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Multiple Myeloma*/diagnostic imaging
Multiple Myeloma*/therapy
Hematopoietic Stem Cell Transplantation*
Humans ; Retrospective Studies ; Hematopoietic Stem Cells/chemistry ; Antigens, CD34/analysis ; Magnetic Resonance Imaging ; Hematopoietic Stem Cell Mobilization/methods ; Granulocyte Colony-Stimulating Factor ; Transplantation, Autologous
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluation of the predictive value of the hematopoietic progenitor cell count using an automated hematology analyzer for CD34+ stem cell mobilization and apheresis product yield.
Autorzy:
Furundarena JR; Hematology Laboratory, Donostia University Hospital (DUH), Donostia, Spain.
Uranga A; Hematology Laboratory, Donostia University Hospital (DUH), Donostia, Spain.
Alkorta A; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Donostia University Hospital (DUH), Donostia, Spain.
González C; Hematology Laboratory, Donostia University Hospital (DUH), Donostia, Spain.
Javier Ferreiro J; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Donostia University Hospital (DUH), Donostia, Spain.
Rey M; Immunology Laboratory, Donostia University Hospital (DUH), Donostia, Spain.
Aragón L; Immunology Laboratory, Donostia University Hospital (DUH), Donostia, Spain.
Urreta I; Clinical Epidemiology Unit, Donostia University Hospital (DUH), Donostia, Spain.
Emparanza JI; Clinical Epidemiology Unit, Donostia University Hospital (DUH), Donostia, Spain.
Redín H; Core Laboratory, Donostia University Hospital (DUH), Donostia, Spain.
Garrido A; Core Laboratory, Donostia University Hospital (DUH), Donostia, Spain.
Araiz M; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Donostia University Hospital (DUH), Donostia, Spain.
Pokaż więcej
Źródło:
International journal of laboratory hematology [Int J Lab Hematol] 2020 Apr; Vol. 42 (2), pp. 170-179. Date of Electronic Publication: 2019 Dec 12.
Typ publikacji:
Journal Article
MeSH Terms:
Automation, Laboratory*
Hematopoietic Stem Cell Mobilization*/instrumentation
Hematopoietic Stem Cell Mobilization*/methods
Blood Component Removal/*instrumentation
Blood Component Removal/*methods
Cell Count/*instrumentation
Cell Count/*methods
Hematopoietic Stem Cells/*metabolism
Adolescent ; Adult ; Antigens, CD34/metabolism ; Biomarkers ; Cell Count/standards ; Clinical Decision-Making ; Disease Management ; Hematopoietic Stem Cells/cytology ; Humans ; Middle Aged ; Predictive Value of Tests ; ROC Curve ; Reproducibility of Results ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cytokine-induced hematopoietic stem and progenitor cell mobilization: unraveling interactions between stem cells and their niche.
Autorzy:
de Kruijf EFM; Section of Stem Cell Biology, Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands.
Fibbe WE; Section of Stem Cell Biology, Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands.
van Pel M; Section of Stem Cell Biology, Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands.
Pokaż więcej
Źródło:
Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2020 Apr; Vol. 1466 (1), pp. 24-38. Date of Electronic Publication: 2019 Apr 21.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Hematopoietic Stem Cell Mobilization*/methods
Hematopoietic Stem Cell Mobilization*/trends
Cell Communication/*physiology
Cytokines/*physiology
Hematopoietic Stem Cells/*physiology
Stem Cell Niche/*physiology
Animals ; Bone Marrow/physiology ; Cytokines/pharmacology ; Granulocyte Colony-Stimulating Factor/pharmacology ; Hematopoietic Stem Cell Transplantation/methods ; Hematopoietic Stem Cell Transplantation/trends ; Hematopoietic Stem Cells/drug effects ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A comparison of four leukapheresis methods to harvest an optimal dose of CD34+ cells: A single center experience.
Autorzy:
Lin Y; Division of Hematology and Oncology, University of Illinois College of Medicine, Chicago, Illinois, USA.
Park Y; Clinical Stem Cell Laboratory, UI Health, Chicago, Illinois, USA.
Khanal A; Division of Hematology and Oncology, University of Illinois College of Medicine, Chicago, Illinois, USA.
Campbell-Lee S; Division of Epidemiology and Biostatistics, University of Illinois, Chicago, Illinois, USA.
Liu L; Division of Epidemiology and Biostatistics, University of Illinois, Chicago, Illinois, USA.; Biorstatistics Shared Resource Center, University of Illinois Cancer Center, Chicago, Illinois, USA.
Chen Z; Division of Epidemiology and Biostatistics, University of Illinois, Chicago, Illinois, USA.; Biorstatistics Shared Resource Center, University of Illinois Cancer Center, Chicago, Illinois, USA.
Patel P; Division of Hematology and Oncology, University of Illinois College of Medicine, Chicago, Illinois, USA.
Vidanovic V; Division of Epidemiology and Biostatistics, University of Illinois, Chicago, Illinois, USA.
Sweiss K; Department of Pharmacy Practice, College of Pharmacy, University of Illinois, Chicago, Illinois, USA.
Irene G; Clinical Stem Cell Laboratory, UI Health, Chicago, Illinois, USA.
Peace D; Division of Hematology and Oncology, University of Illinois College of Medicine, Chicago, Illinois, USA.
Rondelli D; Division of Hematology and Oncology, University of Illinois College of Medicine, Chicago, Illinois, USA.
Mahmud N; Division of Hematology and Oncology, University of Illinois College of Medicine, Chicago, Illinois, USA.; Clinical Stem Cell Laboratory, UI Health, Chicago, Illinois, USA.
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2022 Dec; Vol. 109 (6), pp. 711-718. Date of Electronic Publication: 2022 Sep 12.
Typ publikacji:
Journal Article
MeSH Terms:
Cyclams*
Hematopoietic Stem Cell Transplantation*
Heterocyclic Compounds*
Multiple Myeloma*/diagnosis
Multiple Myeloma*/therapy
Humans ; Hematopoietic Stem Cell Mobilization/methods ; Leukapheresis/methods ; Granulocyte Colony-Stimulating Factor ; Retrospective Studies ; Transplantation, Autologous ; Benzylamines ; Antigens, CD34/metabolism ; Immunologic Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Successful haematopoietic progenitor cell collection by plerixafor in combination with reduced dose granulocyte colony-stimulating factor for severe hypoxemia provoked by high-dose granulocyte colony-stimulating factor administration.
Autorzy:
Kambara Y; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
Asada N; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
Kondo K; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
Sumii Y; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
Fujiwara Y; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
Seike K; Division of Transfusion Medicine, Okayama University Hospital, Okayama, Japan.
Sando Y; Division of Transfusion Medicine, Okayama University Hospital, Okayama, Japan.
Saeki K; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
Nishimori H; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
Fujii K; Division of Transfusion Medicine, Okayama University Hospital, Okayama, Japan.
Fujii N; Division of Transfusion Medicine, Okayama University Hospital, Okayama, Japan.
Matsuoka KI; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
Maeda Y; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
Pokaż więcej
Źródło:
Transfusion medicine (Oxford, England) [Transfus Med] 2022 Dec; Vol. 32 (6), pp. 527-529. Date of Electronic Publication: 2022 Sep 07.
Typ publikacji:
Letter
MeSH Terms:
Heterocyclic Compounds*
Hematopoietic Stem Cell Transplantation*
Humans ; Hematopoietic Stem Cell Mobilization ; Hematopoietic Stem Cells ; Hypoxia ; Granulocyte Colony-Stimulating Factor
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 1203

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies